Insider Trading activities of Dexcom Inc insiders. , Part 3

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Dexcom Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Dexcom Inc since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Dexcom Inc since 2005. The reporting company's ticker symbol is DXCM. The reporting company's CIK number is 1093557.
The total value of stock buying since 2005 is $4,721,044.
The total value of stock sales since 2005 is $539,675,318.
The total value of stock option exercises since 2005 is $34,498,305.



Table 2. Detailed insider stock purchases, sales, and option exercises of Dexcom Inc insiders (DXCM) , Part 3
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2015-07-23 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Sale 14,000 85.37 1,195,166
2015-07-23 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Option Ex 14,000 8.79 123,130
2015-07-22 Balo Andrew K (EVP, Clinical, Regulatory) Sale 10,214 84.78 865,922
2015-07-21 Moy Jeffrey (SVP, Operations) Sale 3,786 83.48 316,055
2015-07-20 Roper Jess (SVP, CFO) Sale 7,000 83.74 586,194
2015-07-20 Roper Jess (SVP, CFO) Option Ex 6,000 9.80 58,800
2015-07-17 Gregg Terrance H (Executive Chairman) Sale 35,750 83.67 2,991,202
2015-07-15 Gregg Terrance H (Executive Chairman) Sale 15,000 81.64 1,224,615
2015-07-15 Skyler Jay S (Director) Sale 20,000 81.69 1,633,880
2015-07-08 Lister John (Sr. VP, General Counsel) Sale 1,776 79.94 141,973
2015-07-08 Valdes Jorge A (CTO) Sale 50,000 80.04 4,002,050
2015-07-08 Valdes Jorge A (CTO) Option Ex 50,000 10.48 524,000
2015-07-08 Balo Andrew K (EVP, Clinical, Regulatory) Sale 4,494 80.22 360,508
2015-07-07 Moy Jeffrey (SVP, Operations) Sale 5,000 79.32 396,614
2015-06-23 Moy Jeffrey (SVP, Operations) Sale 5,154 77.54 399,630
2015-06-23 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Sale 14,000 77.53 1,085,434
2015-06-23 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Option Ex 14,000 7.79 109,060
2015-06-23 Balo Andrew K (EVP, Clinical, Regulatory) Sale 5,573 77.54 432,135
2015-06-23 Balo Andrew K (EVP, Clinical, Regulatory) Option Ex 5,573 9.80 54,615
2015-06-18 Roper Jess (SVP, CFO) Sale 7,000 76.68 536,767
2015-06-18 Roper Jess (SVP, CFO) Option Ex 6,000 8.71 52,290
2015-06-15 Gregg Terrance H (Executive Chairman) Sale 15,000 70.94 1,064,145
2015-06-15 Skyler Jay S (Director) Sale 20,000 70.67 1,413,420
2015-06-12 Gregg Terrance H (Executive Chairman) Sale 25,000 72.30 1,807,425
2015-06-12 Gregg Terrance H (Executive Chairman) Option Ex 25,000 6.85 171,250
2015-06-11 Moy Jeffrey (SVP, Operations) Sale 9,869 73.00 720,437
2015-06-09 Moy Jeffrey (SVP, Operations) Sale 5,000 70.63 353,130
2015-06-09 Valdes Jorge A (CTO) Sale 11,437 70.79 809,590
2015-06-09 Balo Andrew K (EVP, Clinical, Regulatory) Sale 7,500 70.62 529,657
2015-06-09 Balo Andrew K (EVP, Clinical, Regulatory) Option Ex 7,500 9.80 73,500
2015-06-08 Lister John (Sr. VP, General Counsel) Sale 1,776 72.03 127,932
2015-06-08 Valdes Jorge A (CTO) Sale 8,243 72.07 594,081
2015-06-08 Valdes Jorge A (CTO) Option Ex 8,243 13.45 110,868
2015-06-03 Gregg Terrance H (Executive Chairman) Sale 25,000 72.73 1,818,274
2015-06-03 Gregg Terrance H (Executive Chairman) Option Ex 25,000 5.02 125,499
2015-06-02 Gregg Terrance H (Executive Chairman) Sale 5,000 73.12 365,600
2015-06-02 Gregg Terrance H (Executive Chairman) Option Ex 5,000 3.19 15,950
2015-06-01 Gregg Terrance H (Executive Chairman) Sale 10,000 72.75 727,500
2015-06-01 Gregg Terrance H (Executive Chairman) Option Ex 10,000 3.19 31,900
2015-05-27 Doubleday Richard (EVP, Chief Commercial Officer) Sale 3,258 70.73 230,431
2015-05-27 Moy Jeffrey (SVP, Operations) Sale 16,791 70.00 1,175,370
2015-05-26 Moy Jeffrey (SVP, Operations) Sale 5,000 68.24 341,215
2015-05-26 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Sale 14,000 68.23 955,178
2015-05-26 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Option Ex 14,000 7.79 109,060
2015-05-19 Gregg Terrance H (Executive Chairman) Sale 17,500 69.58 1,217,562
2015-05-19 Gregg Terrance H (Executive Chairman) Option Ex 17,500 3.19 55,825
2015-05-18 Moy Jeffrey (SVP, Operations) Sale 15,586 69.20 1,078,551
2015-05-18 Roper Jess (SVP, CFO) Sale 7,000 69.25 484,763
2015-05-18 Roper Jess (SVP, CFO) Option Ex 6,000 7.63 45,780
2015-05-18 Balo Andrew K (EVP, Clinical, Regulatory) Sale 7,500 68.46 513,472
2015-05-18 Balo Andrew K (EVP, Clinical, Regulatory) Option Ex 7,500 9.80 73,500
2015-05-18 Gregg Terrance H (Executive Chairman) Sale 37,500 70.15 2,630,737
2015-05-18 Gregg Terrance H (Executive Chairman) Option Ex 37,500 3.19 119,625
2015-05-15 Gregg Terrance H (Executive Chairman) Sale 15,000 68.19 1,022,775
2015-05-14 Gregg Terrance H (Executive Chairman) Sale 30,000 68.47 2,053,950
2015-05-14 Gregg Terrance H (Executive Chairman) Option Ex 30,000 5.02 150,600
2015-05-12 Moy Jeffrey (SVP, Operations) Sale 5,000 66.58 332,875
2015-05-12 Valdes Jorge A (CTO) Sale 11,194 68.41 765,770
2015-05-11 Moy Jeffrey (SVP, Operations) Sale 15,303 68.25 1,044,490
2015-05-11 Valdes Jorge A (CTO) Sale 11,440 67.97 777,565
2015-05-11 Gregg Terrance H (Executive Chairman) Sale 3,517 68.65 241,442
2015-05-11 Gregg Terrance H (Executive Chairman) Option Ex 3,517 3.19 11,219
2015-05-08 Lister John (Sr. VP, General Counsel) Sale 4,173 68.49 285,825
2015-05-08 Lister John (Sr. VP, General Counsel) Option Ex 2,396 8.85 21,204
2015-05-08 Valdes Jorge A (CTO) Sale 8,244 68.51 564,788
2015-05-08 Valdes Jorge A (CTO) Option Ex 8,244 13.45 110,881
2015-05-08 Gregg Terrance H (Executive Chairman) Sale 51,483 68.09 3,505,683
2015-05-08 Gregg Terrance H (Executive Chairman) Option Ex 51,483 5.02 258,444
2015-05-07 Gregg Terrance H (Executive Chairman) Sale 40,000 67.52 2,700,920
2015-05-07 Gregg Terrance H (Executive Chairman) Option Ex 40,000 6.33 253,200
2015-05-04 Balo Andrew K (EVP, Clinical, Regulatory) Sale 7,500 67.99 509,902
2015-05-04 Balo Andrew K (EVP, Clinical, Regulatory) Option Ex 7,500 9.80 73,500
2015-05-04 Sayer Kevin R (President & CEO) Sale 25,000 68.01 1,700,325
2015-05-04 Gregg Terrance H (Executive Chairman) Sale 20,000 68.06 1,361,279
2015-05-04 Gregg Terrance H (Executive Chairman) Option Ex 20,000 8.95 179,000
2015-04-30 Gregg Terrance H (Executive Chairman) Sale 14,250 67.13 956,602
2015-04-28 Moy Jeffrey (SVP, Operations) Sale 5,000 67.55 337,750
2015-04-27 Moy Jeffrey (SVP, Operations) Sale 5,000 69.27 346,370
2015-04-27 Moy Jeffrey (SVP, Operations) Option Ex 5,000 9.36 46,800
2015-04-23 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Sale 14,000 69.84 977,718
2015-04-23 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Option Ex 14,000 7.79 109,060
2015-04-23 Balo Andrew K (EVP, Clinical, Regulatory) Sale 7,500 69.65 522,352
2015-04-23 Balo Andrew K (EVP, Clinical, Regulatory) Option Ex 7,500 9.80 73,500
2015-04-21 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Sale 25,709 69.52 1,787,289
2015-04-21 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Option Ex 25,709 20.65 530,890
2015-04-20 Roper Jess (SVP, CFO) Sale 7,000 68.03 476,238
2015-04-20 Roper Jess (SVP, CFO) Option Ex 6,000 7.63 45,780
2015-04-15 Gregg Terrance H (Executive Chairman) Sale 15,000 67.56 1,013,415
2015-04-14 Moy Jeffrey (SVP, Operations) Sale 5,000 67.32 336,584
2015-04-13 Moy Jeffrey (SVP, Operations) Sale 5,000 67.78 338,905
2015-04-13 Moy Jeffrey (SVP, Operations) Option Ex 5,000 9.36 46,800
2015-04-10 Moy Jeffrey (SVP, Operations) Sale 10,766 65.77 708,036
2015-04-10 Moy Jeffrey (SVP, Operations) Option Ex 10,766 9.04 97,303
2015-04-09 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Sale 20,000 65.03 1,300,560
2015-04-09 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Option Ex 20,000 15.99 319,800
2015-04-09 Valdes Jorge A (CTO) Sale 11,440 64.78 741,128
2015-04-09 Balo Andrew K (EVP, Clinical, Regulatory) Sale 7,500 64.55 484,147
2015-04-09 Balo Andrew K (EVP, Clinical, Regulatory) Option Ex 7,500 9.80 73,500
2015-04-08 Lister John (Sr. VP, General Counsel) Sale 5,039 63.84 321,679
2015-04-08 Lister John (Sr. VP, General Counsel) Option Ex 5,039 8.85 44,595
2015-04-08 Valdes Jorge A (CTO) Sale 8,244 63.81 526,049
2015-04-08 Valdes Jorge A (CTO) Option Ex 8,244 13.45 110,881
2015-03-25 Balo Andrew K (EVP, Clinical, Regulatory) Sale 7,500 61.05 457,852
2015-03-25 Balo Andrew K (EVP, Clinical, Regulatory) Option Ex 7,500 9.80 73,500
2015-03-23 Doubleday Richard (EVP, Chief Commercial Officer) Sale 4,000 61.25 244,992
2015-03-23 Doubleday Richard (EVP, Chief Commercial Officer) Option Ex 4,000 6.03 24,120
2015-03-23 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Sale 14,000 61.33 858,676
2015-03-23 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Option Ex 14,000 7.79 109,060
2015-03-20 Valdes Jorge A (CTO) Sale 27,100 62.32 1,688,872
2015-03-18 Roper Jess (SVP, CFO) Sale 7,000 62.41 436,863
2015-03-18 Roper Jess (SVP, CFO) Option Ex 6,000 7.63 45,780
2015-03-17 Gregg Terrance H (Executive Chairman) Sale 15,000 62.82 942,300
2015-03-13 Skyler Jay S (Director) Sale 16,500 60.01 990,231
2015-03-13 Skyler Jay S (Director) Option Ex 16,500 21.09 348,067
2015-03-12 Doubleday Richard (EVP, Chief Commercial Officer) Sale 20,000 59.11 1,182,180
2015-03-12 Doubleday Richard (EVP, Chief Commercial Officer) Option Ex 20,000 9.80 196,000
2015-03-12 Valdes Jorge A (CTO) Sale 11,138 59.78 665,829
2015-03-12 Skyler Jay S (Director) Sale 6,936 60.00 416,160
2015-03-12 Skyler Jay S (Director) Option Ex 6,936 16.19 112,293
2015-03-11 Balo Andrew K (EVP, Clinical, Regulatory) Sale 7,500 58.58 439,365
2015-03-11 Balo Andrew K (EVP, Clinical, Regulatory) Option Ex 7,500 9.80 73,500
2015-03-11 Skyler Jay S (Director) Sale 21,564 60.00 1,293,904
2015-03-11 Skyler Jay S (Director) Option Ex 21,564 12.00 258,768
2015-03-09 Lister John (Sr. VP, General Counsel) Sale 5,039 58.77 296,157
2015-03-09 Lister John (Sr. VP, General Counsel) Option Ex 5,039 8.85 44,595
2015-03-09 Valdes Jorge A (CTO) Sale 14,882 59.30 882,443
2015-03-09 Valdes Jorge A (CTO) Option Ex 8,244 13.45 110,881
2015-03-05 Kahn Barbara (Director) Sale 3,000 60.29 180,873
2015-03-02 Moy Jeffrey (SVP, Operations) Sale 5,000 60.33 301,650
2015-03-02 Moy Jeffrey (SVP, Operations) Option Ex 5,000 9.80 49,000
2015-02-24 Balo Andrew K (EVP, Clinical, Regulatory) Sale 7,500 62.22 466,635
2015-02-24 Balo Andrew K (EVP, Clinical, Regulatory) Option Ex 7,500 9.80 73,500
2015-02-23 Doubleday Richard (EVP, Chief Commercial Officer) Sale 4,000 63.58 254,336
2015-02-23 Doubleday Richard (EVP, Chief Commercial Officer) Option Ex 4,000 6.03 24,120
2015-02-23 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Sale 14,000 63.43 888,020
2015-02-23 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Option Ex 14,000 7.79 109,060
2015-02-18 Roper Jess (SVP, CFO) Sale 7,000 61.87 433,097
2015-02-18 Roper Jess (SVP, CFO) Option Ex 6,000 7.63 45,780
2015-02-17 Moy Jeffrey (SVP, Operations) Sale 5,044 62.11 313,292
2015-02-17 Moy Jeffrey (SVP, Operations) Option Ex 5,044 9.80 49,431
2015-02-17 Gregg Terrance H (Executive Chairman) Sale 15,000 62.19 932,805
2015-02-10 Balo Andrew K (EVP, Clinical, Regulatory) Sale 7,500 61.41 460,605
2015-02-10 Balo Andrew K (EVP, Clinical, Regulatory) Option Ex 7,500 9.80 73,500
2015-02-09 Lister John (Sr. VP, General Counsel) Sale 5,039 61.66 310,694
2015-02-09 Lister John (Sr. VP, General Counsel) Option Ex 5,039 6.71 33,836
2015-02-09 Valdes Jorge A (CTO) Sale 9,170 61.67 565,486
2015-02-09 Valdes Jorge A (CTO) Option Ex 8,244 13.45 110,881
2015-02-02 Moy Jeffrey (SVP, Operations) Sale 5,000 60.69 303,425
2015-02-02 Moy Jeffrey (SVP, Operations) Option Ex 5,000 9.80 49,000
2015-01-26 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Sale 10,532 62.18 654,890

Insider trading activities including stock purchases, stock sales, and option exercises of DXCM listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Dexcom Inc (symbol DXCM, CIK number 1093557) see the Securities and Exchange Commission (SEC) website.